EdgeBio Receives CLIA Certification for its Next-Generation Sequencing Operation
News Apr 26, 2012
EdgeBio will begin accepting clinical samples immediately for its first CLIA based test, the Clinical Exome Test, featuring whole exome sequencing.
“This marks the next phase of the natural evolution of our sequencing operations at EdgeBio,” said Dean Gaalaas, President and CEO of EdgeBio. “For the past three years we have been building expertise in both the generation and analysis of data via NGS in a research setting. Receiving CLIA certification now allows us to leverage this expertise to help clinicians better diagnose and treat their patients.”
EdgeBio, founded in 1990, has been a pioneer in DNA sequencing for over two decades. The company launched its sequencing and bioinformatics services in 2009 and has sequenced over 3500 samples to date. Dr. Sherri Bale, FACMG, of GeneDx, will serve as Laboratory Director for CLIA Operations. Dr. Bale is a Board-Certified Ph.D. Medical Geneticist, and a Founding Member of the American College of Medical Genetics. She has more than 30 years of experience in clinical, cytogenetic, and molecular genetics research and has authored over 130 papers, book chapters, and books in the field.
Single-stranded Origami Technology Drives Drug Delivery Systems and Pharmaceutical Nanofactories ForwardNews
First nanotechnological approach enables the design and replication of complex single-stranded DNA and RNA origami with potential for drug delivery and nanofabrication.READ MORE
Bringing ‘Avatar’-Like Glowing Plants to the Real WorldNews
The 2009 film “Avatar” created a lush imaginary world, illuminated by magical, glowing plants. Now researchers are starting to bring this spellbinding vision to life to help reduce our dependence on artificial lighting.READ MORE
Cracking the Code of Coenzyme Q BiosynthesisNews
Coenzyme Q is a vital cog in the body’s energy-producing machinery, a kind of chemical gateway in the conversion of food into cellular fuel. Researchers are developing new tools to shed light on CoQ function, primarily by finding and defining proteins that have a direct link to the chemical. This includes the development of a new multi-omic strategy to identify the global function of an RNA-binding protein that has long been associated with mitochondria and its role in CoQ biosynthesis.READ MORE